Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia.
Bosch-Marcé M, Pola R, Wecker AB, Silver M, Weber A, Luedemann C, Curry C, Murayama T, Kearney M, Yoon YS, Malinow MR, Asahara T, Isner JM, Losordo DW. Bosch-Marcé M, et al. Among authors: weber a. Vasc Med. 2005 Feb;10(1):15-22. doi: 10.1191/1358863x05vm585oa. Vasc Med. 2005. PMID: 15920995
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
Kirchmair R, Walter DH, Ii M, Rittig K, Tietz AB, Murayama T, Emanueli C, Silver M, Wecker A, Amant C, Schratzberger P, Yoon YS, Weber A, Panagiotou E, Rosen KM, Bahlmann FH, Adelman LS, Weinberg DH, Ropper AH, Isner JM, Losordo DW. Kirchmair R, et al. Among authors: weber a. Circulation. 2005 May 24;111(20):2662-70. doi: 10.1161/CIRCULATIONAHA.104.470849. Epub 2005 May 16. Circulation. 2005. PMID: 15897348
Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF.
Kirchmair R, Tietz AB, Panagiotou E, Walter DH, Silver M, Yoon YS, Schratzberger P, Weber A, Kusano K, Weinberg DH, Ropper AH, Isner JM, Losordo DW. Kirchmair R, et al. Among authors: weber a. Mol Ther. 2007 Jan;15(1):69-75. doi: 10.1038/sj.mt.6300019. Mol Ther. 2007. PMID: 17164777 Free article.
Ethnic and racial differences in children and young people with respiratory and neurological post-acute sequelae of SARS-CoV-2: an electronic health record-based cohort study from the RECOVER Initiative.
Rao S, Azuero-Dajud R, Lorman V, Landeo-Gutierrez J, Rhee KE, Ryu J, Kim C, Carmilani M, Gross RS, Mohandas S, Suresh S, Bailey LC, Castro V, Senathirajah Y, Esquenazi-Karonika S, Murphy S, Caddle S, Kleinman LC, Castro-Baucom L, Oliveira CR, Klein JD, Chung A, Cowell LG, Madlock-Brown C, Geary CR, Sills MR, Thorpe LE, Szmuszkovicz J, Tantisira KG; RECOVER EHR and; RECOVER Pediatric Cohorts. Rao S, et al. EClinicalMedicine. 2025 Jan 2;80:103042. doi: 10.1016/j.eclinm.2024.103042. eCollection 2025 Feb. EClinicalMedicine. 2025. PMID: 39850015 Free PMC article.
WHO guidelines on waist circumference and physical activity and their joint association with cancer risk.
Bohmann P, Stein MJ, Amadou A, Baurecht H, Fervers B, Fontvieille E, Freisling H, Friedenreich C, Konzok J, Peruchet-Noray L, Leitzmann MF, Sedlmeier AM, Weber A. Bohmann P, et al. Among authors: weber a. Br J Sports Med. 2025 Jan 22:bjsports-2024-108708. doi: 10.1136/bjsports-2024-108708. Online ahead of print. Br J Sports Med. 2025. PMID: 39843229 Free article.
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancer.
Rudalska R, Harbig J, Forster M, Woelffing P, Esposito A, Kudolo M, Botezatu A, Haller V, Janssen N, Holzmayer S, Nahidino P, Trompak O, Pantsar T, Kronenberger T, Yurttas C, Rist E, Weber ANR, Dahlke MH, Ott G, Koenigsrainer A, Rothbauer U, Maerklin M, Muerdter T, Schwab M, Singer S, Zender L, Laufer S, Dauch D. Rudalska R, et al. Among authors: weber anr. Nat Cancer. 2025 Jan 16. doi: 10.1038/s43018-024-00899-7. Online ahead of print. Nat Cancer. 2025. PMID: 39820127
4,250 results